Analysts See $0.64 EPS for Pfizer Inc. (PFE); 3 Analysts Are Bullish MEDNAX (MD) Last Week

October 11, 2017 - By Darrin Black

Among 14 analysts covering MEDNAX (NYSE:MD), 3 have Buy rating, 1 Sell and 10 Hold. Therefore 21% are positive. MEDNAX had 34 analyst reports since July 31, 2015 according to SRatingsIntel. The company was maintained on Tuesday, August 25 by Stifel Nicolaus. The firm earned “Neutral” rating on Wednesday, November 9 by Mizuho. The stock has “Hold” rating by Jefferies on Thursday, August 31. The rating was maintained by Mizuho on Friday, October 28 with “Buy”. Jefferies maintained the stock with “Buy” rating in Friday, August 26 report. The stock of MEDNAX Inc (NYSE:MD) earned “Neutral” rating by Robert W. Baird on Tuesday, March 21. The stock has “Hold” rating by Jefferies on Monday, June 5. The company was maintained on Wednesday, August 17 by Citigroup. The firm earned “Hold” rating on Thursday, October 5 by Robert W. Baird. On Tuesday, March 8 the stock rating was maintained by Stifel Nicolaus with “Buy”. See MEDNAX Inc (NYSE:MD) latest ratings:

05/10/2017 Broker: Robert W. Baird Rating: Hold New Target: $47.0 Maintain
18/09/2017 Broker: KeyBanc Capital Markets Old Rating: Sector Weight New Rating: Overweight Upgrade
01/09/2017 Broker: Robert W. Baird Rating: Hold New Target: $47.0 Maintain
31/08/2017 Broker: Stifel Nicolaus Rating: Hold New Target: $48.0 Maintain
31/08/2017 Broker: Jefferies Rating: Hold New Target: $46.0 Maintain
28/07/2017 Broker: Jefferies Rating: Hold New Target: $46.0000 Maintain
05/06/2017 Broker: Jefferies Rating: Hold New Target: $50.0000 Maintain
22/06/2017 Broker: Stephens Old Rating: Equal-Weight New Rating: Overweight Upgrade
30/05/2017 Broker: Mizuho Rating: Neutral Old Target: $64.00 New Target: $58.00 Maintain
25/05/2017 Broker: Stifel Nicolaus Rating: Hold Old Target: $65.00 New Target: $58.00 Maintain

Analysts expect Pfizer Inc. (NYSE:PFE) to report $0.64 EPS on November, 7.They anticipate $0.03 EPS change or 4.92% from last quarter’s $0.61 EPS. PFE’s profit would be $3.81 billion giving it 14.22 P/E if the $0.64 EPS is correct. After having $0.67 EPS previously, Pfizer Inc.’s analysts see -4.48% EPS growth. The stock increased 0.72% or $0.26 during the last trading session, reaching $36.4. About shares traded. Pfizer Inc. (NYSE:PFE) has declined 2.76% since October 11, 2016 and is downtrending. It has underperformed by 19.46% the S&P500.

Pfizer Inc. is a research-based global biopharmaceutical company. The company has market cap of $216.77 billion. The Firm is engaged in the discovery, development and manufacture of healthcare products. It has a 26.51 P/E ratio. The Company’s global portfolio includes medicines and vaccines, as well as consumer healthcare products.

Investors sentiment decreased to 0.94 in 2017 Q2. Its down 0.01, from 0.95 in 2017Q1. It worsened, as 58 investors sold Pfizer Inc. shares while 716 reduced holdings. 112 funds opened positions while 612 raised stakes. 4.02 billion shares or 1.07% less from 4.06 billion shares in 2017Q1 were reported. Hightower Advsr Limited Liability Company owns 2.27 million shares for 0.66% of their portfolio. Mark Sheptoff Fincl Planning Ltd Liability Com holds 1.03% in Pfizer Inc. (NYSE:PFE) or 44,698 shares. Cypress Mgmt Ltd Company owns 422,226 shares or 3.39% of their US portfolio. First National Bank & Trust holds 1.05% or 181,877 shares in its portfolio. Mcmillion Capital Mgmt holds 95,485 shares or 2.15% of its portfolio. Carlson Cap Limited Partnership invested in 0.2% or 426,211 shares. Cap Guardian Tru Company, a California-based fund reported 178,214 shares. Brave Asset Mgmt stated it has 1.29% in Pfizer Inc. (NYSE:PFE). Mason Street Advsr Ltd Llc holds 0.7% or 828,271 shares in its portfolio. Blue Financial Cap Inc stated it has 0.99% of its portfolio in Pfizer Inc. (NYSE:PFE). 66,312 were accumulated by Checchi Cap Advisers Ltd Liability Corp. Norinchukin Bancshares The reported 0.52% in Pfizer Inc. (NYSE:PFE). Thrivent For Lutherans, Minnesota-based fund reported 4.27 million shares. Beach Invest Counsel Pa accumulated 0.53% or 155,230 shares. Moreover, Bnp Paribas Asset Mngmt has 0.27% invested in Pfizer Inc. (NYSE:PFE) for 914,884 shares.

Among 20 analysts covering Pfizer (NYSE:PFE), 8 have Buy rating, 1 Sell and 11 Hold. Therefore 40% are positive. Pfizer had 58 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Hold” rating by Jefferies given on Thursday, October 13. The firm has “Outperform” rating given on Monday, May 9 by Credit Suisse. The rating was maintained by BMO Capital Markets with “Hold” on Monday, June 12. Societe Generale initiated Pfizer Inc. (NYSE:PFE) on Wednesday, April 6 with “Hold” rating. The stock of Pfizer Inc. (NYSE:PFE) has “Buy” rating given on Thursday, September 14 by Piper Jaffray. The stock of Pfizer Inc. (NYSE:PFE) has “Buy” rating given on Wednesday, August 2 by Piper Jaffray. The company was initiated on Tuesday, December 1 by Barclays Capital. The stock has “Overweight” rating by Morgan Stanley on Friday, October 2. Jefferies maintained Pfizer Inc. (NYSE:PFE) on Wednesday, August 16 with “Hold” rating. The stock of Pfizer Inc. (NYSE:PFE) earned “Buy” rating by Cowen & Co on Monday, August 14.